Risk factors and prodromal markers and the development of Parkinson’s disease

被引:0
|
作者
Stefanie Lerche
Klaus Seppi
Stefanie Behnke
Inga Liepelt-Scarfone
Jana Godau
Philipp Mahlknecht
Alexandra Gaenslen
Kathrin Brockmann
Karin Srulijes
Heiko Huber
Isabel Wurster
Heike Stockner
Stefan Kiechl
Johann Willeit
Arno Gasperi
Klaus Fassbender
Werner Poewe
Daniela Berg
机构
[1] University of Tuebingen,Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology
[2] University of Tuebingen,German Center for Neurodegenerative Diseases (DZNE)
[3] University of Innsbruck,Department of Neurology
[4] University of Homburg/Saar,Department of Neurology
[5] Bruneck Hospital,Department of Neurology
来源
Journal of Neurology | 2014年 / 261卷
关键词
Risk factor; Prodromal marker; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Identification of risk factors and prodromal markers for Parkinson’s disease (PD) and the understanding of the point in time of first occurrence is essential for the early detection of incident PD. In this three-center longitudinal, observational study, we evaluated the specific risk for PD associated with single or combinations of risk factors and prodromal markers. In addition, we evaluated which risk factors and prodromal markers emerge at which time before the diagnosis of PD. Of the 1,847 at-baseline PD-free individuals ≥50 years, 1,260 underwent the 5-year follow-up assessment. There were 21 cases of incident PD during the study period. Enlarged hyperechogenic substantia nigra was the most frequent baseline sign in individuals developing PD after 3 years (80.0 %) and 5 years (85.7 %) compared to healthy controls (17.5 %) followed by the occurrence of mild parkinsonian signs and hyposmia. Evaluation of the signs at the first follow-up assessment showed that individuals developing PD after two additional years showed the same pattern of signs as individuals who developed PD 3 years after baseline assessment.
引用
收藏
页码:180 / 187
页数:7
相关论文
共 50 条
  • [31] The Concept of Prodromal Parkinson's Disease
    Mahlknecht, Philipp
    Seppi, Klaus
    Poewe, Werner
    JOURNAL OF PARKINSONS DISEASE, 2015, 5 (04) : 681 - 697
  • [32] Biology of prodromal Parkinson's disease
    Truong, Daniel
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [33] In pursuit of prodromal Parkinson's disease
    Lang, Anthony E.
    LANCET NEUROLOGY, 2015, 14 (01): : 27 - 28
  • [34] Search for changes (markers) in the blood of patients at risk of developing Parkinson's disease at the prodromal stage and their validation in animal models of the disease
    Blokhin, V.
    Pavlova, E.
    Katunina, E.
    Kucheryanu, V.
    Ugrumov, M.
    FEBS OPEN BIO, 2022, 12 : 216 - 217
  • [35] Risk disclosure in prodromal Parkinson?s disease-A survey of neurologists
    Kayis, Gorkem
    Yilmaz, Rezzak
    Arda, Berna
    Akbostanci, M. Cenk
    PARKINSONISM & RELATED DISORDERS, 2023, 106
  • [36] Prodromal RBD and the risk of cognitive impairment in Parkinson's disease (PD)
    Martinez-Nunez, A.
    Hutchinson, H.
    Lavu, V.
    Yuan, Q.
    Dwarampudi, J.
    Wong, J.
    MOVEMENT DISORDERS, 2024, 39 : S170 - S170
  • [37] Markers of prodromal Alzheimer's disease
    de Souza, L. C.
    Sarazin, M.
    Uspenskaya, O.
    Habert, M. -O.
    Lamari, F.
    Lehericy, S.
    Dubois, B.
    REVUE NEUROLOGIQUE, 2012, 168 (11) : 815 - 824
  • [38] Parkinson's disease risk factors
    Allam, MF
    del Castillo, AS
    Navajas, RFC
    REVISTA DE NEUROLOGIA, 2003, 36 (08) : 749 - 755
  • [39] Biofluid Markers and Tissue Biopsies Analyses for the Prodromal and Earliest Phase of Parkinson's Disease
    Pilotto, Andrea
    Zanusso, Gianluigi
    Antelmi, Elena
    Okuzumi, Ayami
    Zatti, Cinzia
    Lupini, Alessandro
    Bongianni, Matilde
    Padovani, Alessandro
    Hattori, Nobutaka
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 : S333 - S344
  • [40] Motor and Non-Motor Features of Individuals with Prodromal Markers of Parkinson's Disease
    Baker, J. M.
    Hughes, K. C.
    Stephen, C. D.
    Schwarzschild, M. A.
    Ascherio, A.
    MOVEMENT DISORDERS, 2017, 32 (09) : E3 - E3